Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity

v3.22.2.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common stock, beginning balance (in shares) at Dec. 31, 2020   121,922,532      
Beginning balance at Dec. 31, 2020 $ 395,204,334 $ 121,923 $ 504,112,442 $ (109,030,031) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock options and warrants exercised, and vesting of restricted shares (in shares) [1]   1,700,343      
Stock options and warrants exercised, and vesting of restricted shares [1] (2,083,046) $ 1,700 (2,084,746)    
Stock-based compensation 3,253,546   3,253,546    
Net loss (245,241,272)     (245,241,272)  
Other comprehensive loss (10,200,000)       (10,200,000)
Common stock, ending balance (in shares) at Sep. 30, 2021   123,622,875      
Ending balance at Sep. 30, 2021 140,933,562 $ 123,623 505,281,242 (354,271,303) (10,200,000)
Common stock, beginning balance (in shares) at Jun. 30, 2021   123,414,045      
Beginning balance at Jun. 30, 2021 222,841,401 $ 123,414 506,073,876 (273,155,889) (10,200,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock options and warrants exercised, and vesting of restricted shares (in shares) [1]   208,830      
Stock options and warrants exercised, and vesting of restricted shares [1] (2,013,630) $ 209 (2,013,839)    
Stock-based compensation 1,221,205   1,221,205    
Net loss (81,115,414)     (81,115,414)  
Other comprehensive loss 0       0
Common stock, ending balance (in shares) at Sep. 30, 2021   123,622,875      
Ending balance at Sep. 30, 2021 $ 140,933,562 $ 123,623 505,281,242 (354,271,303) (10,200,000)
Common stock, beginning balance (in shares) at Dec. 31, 2021 151,915,455 151,915,455      
Beginning balance at Dec. 31, 2021 $ 174,692,773 $ 151,916 686,318,201 (510,374,844) (1,402,500)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued in exchange of convertible notes (in shares)   7,833,666      
Common stock issued in exchange of convertible notes 25,381,078 $ 7,834 25,373,244    
Common stock issued through At-The-Market offering (in shares)   98,986      
Common stock issued through At-The-Market offering 248,695 $ 99 248,596    
Stock options and warrants exercised, and vesting of restricted shares (in shares) [2]   599,970      
Stock options and warrants exercised, and vesting of restricted shares [2] (466,532) $ 599 (467,131)    
Stock-based compensation 8,627,977   8,627,977    
Net loss (78,620,308)     (78,620,308)  
Other comprehensive loss $ 1,402,500       1,402,500
Common stock, ending balance (in shares) at Sep. 30, 2022 160,448,077 160,448,077      
Ending balance at Sep. 30, 2022 $ 131,266,183 $ 160,448 720,100,887 (588,995,152) 0
Common stock, beginning balance (in shares) at Jun. 30, 2022   160,058,512      
Beginning balance at Jun. 30, 2022 163,828,453 $ 160,059 717,258,045 (553,589,651) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock options and warrants exercised, and vesting of restricted shares (in shares) [2]   389,565      
Stock options and warrants exercised, and vesting of restricted shares [2] (142,044) $ 389 (142,433)    
Stock-based compensation 2,985,275   2,985,275    
Net loss $ (35,405,501)     (35,405,501)  
Common stock, ending balance (in shares) at Sep. 30, 2022 160,448,077 160,448,077      
Ending balance at Sep. 30, 2022 $ 131,266,183 $ 160,448 $ 720,100,887 $ (588,995,152) $ 0
[1] Net of tax payments related to shares withheld for option exercises and vested stock.
[2] Net of tax payments related to shares withheld for option exercises and vested stock.